Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1976.005.25 (+0.27 %)

PREV CLOSE ( ) 1970.75

OPEN PRICE ( ) 1971.25

BID PRICE (QTY) 1971.70 (3)

OFFER PRICE (QTY) 1975.75 (3)

VOLUME 3730

TODAY'S LOW / HIGH ( )1947.85 1995.10

52 WK LOW / HIGH ( )1200 2220.95

NSE1973.402.5 (+0.13 %)

PREV CLOSE( ) 1970.90

OPEN PRICE ( ) 1987.20

BID PRICE (QTY) 1973.40 (1)

OFFER PRICE (QTY) 1975.10 (1)

VOLUME 144919

TODAY'S LOW / HIGH( ) 1948.00 2000.90

52 WK LOW / HIGH ( )1277.8 2220.95

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

14249.09

13840.52

14058.33

14017.1

Total Expenditure

10773.94

10240.97

11087.76

11373.13

PBIDT (Excl OI)

3475.15

3599.55

2970.57

2643.97

Other Income

440.29

584.94

596.59

514.26

Operating Profit

3915.44

4184.49

3567.16

3158.23

Interest

74.5

228.22

61.12

56.16

Exceptional Items

PBDT

3840.94

3956.27

3506.04

3102.07

Depreciation

957.61

963.25

938.26

919.62

Profit Before Tax

2883.33

2993.02

2567.78

2182.45

Tax

1017.92

946.1

932.46

744.84

Provisions and contingencies

Profit After Tax

1865.41

2046.92

1635.32

1437.61

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1865.41

2046.92

1635.32

1437.61

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1865.41

2046.92

1635.32

1437.61

Equity Capital

164.76

164.75

Face Value (IN RS)

Reserves

Calculated EPS

11.32

12.42

9.92

8.72

Calculated EPS (Annualised)

45.28

49.69

39.70

34.90

No of Public Share Holdings

79362489

79357789

% of Public Share Holdings

48.17

PBIDTM% (Excl OI)

24.38

26.00

21.13

18.86

PBIDTM%

27.47

30.23

25.37

22.53

PBDTM%

26.95

28.58

24.93

22.13

PBTM%

20.23

21.62

18.26

15.56

PATM%

13.09

14.78

11.63

10.25

Notes

Risk Disclosures on Derivatives

Quarterly Results

GLAND PHARMA LTD.